News
2020 Report of the Committee on Law Enforcement/Legislation
2020 Report of the Committee on Constitution and Bylaws
NABP Urges Congressional Leaders to Continue Supporting Federal Programs to Combat Both Opioid Epidemic and COVID-19
Four-Month Pilot Aims to Address Illegal Online Opioid Sales
Recognition Resolution (Resolution 116-5-20)
Task Force on Medication Reuse (Resolution 116-4-20)
Incorporating Criminal Background Checks into the NABP e-Profile System (Resolution 116-3-20)
Development and Administration of Patient-Specific Biologics (Resolution 116-2-20)
State Pharmacy Boards’ Responses to FDA Form 483 Observations (Resolution 116-1-20)
Topics
- Uncategorized
- Counterfeit Drugs
- Adverse Drug Events
- Committee and Task Force Reports
- Compounding
- Controlled Substances
- Diversion
- Federal Regulations
- Medication Collection and Disposal
- Medication Errors
- Medication Therapy Management
- Officer Reports
- Patient Safety
- Practitioner Prescriber
- Prescription Monitoring Program
- Resolutions
- NABP Program
- Pharmacist Licensure
- Prescriptions
- Technician Licensure or Certification
- Prescription Drug Abuse
- State Rules and Regulations
- Pharmacies
- Internet Pharmacies
- Innovations
- Coronavirus disease 2019 (COVID-19)